Upgrade to SI Premium - Free Trial

Teva Pharma (TEVA) Lower as Momenta's (MNTA) Generic 40mg Copaxone Gets One Step Closer - BTIG

January 30, 2018 10:00 AM
BTIG analyst Timothy Chiang reiterated a Neutral rating on Teva Pharma (NYSE: TEVA) after Momenta (NASDAQ: MNTA) announced that the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles